Changes in Protein Structural Motifs upon Post-Translational Modification in Kidney Cancer
Dmitry Tikhonov,
Liudmila Kulikova,
Vladimir Rudnev,
Arthur T. Kopylov,
Amir Taldaev,
Alexander Stepanov,
Kristina Malsagova,
Alexander Izotov,
Dmitry Enikeev,
Natalia Potoldykova,
Anna Kaysheva
Affiliations
Dmitry Tikhonov
Institute of Mathematical Problems of Biology RAS—The Branch of Keldysh Institute of Applied Mathematics of Russian Academy of Sciences, 142290 Pushchino, Russia
Liudmila Kulikova
Institute of Mathematical Problems of Biology RAS—The Branch of Keldysh Institute of Applied Mathematics of Russian Academy of Sciences, 142290 Pushchino, Russia
Vladimir Rudnev
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, Russia
Arthur T. Kopylov
V.N. Orekhovich Institute of Biomedical Chemistry, 119121 Moscow, Russia
Amir Taldaev
V.N. Orekhovich Institute of Biomedical Chemistry, 119121 Moscow, Russia
Alexander Stepanov
V.N. Orekhovich Institute of Biomedical Chemistry, 119121 Moscow, Russia
Kristina Malsagova
V.N. Orekhovich Institute of Biomedical Chemistry, 119121 Moscow, Russia
Alexander Izotov
V.N. Orekhovich Institute of Biomedical Chemistry, 119121 Moscow, Russia
Dmitry Enikeev
Institute of Urology and Reproductive Health, Sechenov University, 119121 Moscow, Russia
Natalia Potoldykova
Institute of Urology and Reproductive Health, Sechenov University, 119121 Moscow, Russia
Anna Kaysheva
V.N. Orekhovich Institute of Biomedical Chemistry, 119121 Moscow, Russia
Post-translational modification (PTM) leads to conformational changes in protein structure, modulates the biological function of proteins, and, consequently, changes the signature of metabolic transformations and the immune response in the body. Common PTMs are reversible and serve as a mechanism for modulating metabolic trans-formations in cells. It is likely that dysregulation of post-translational cellular signaling leads to abnormal proliferation and oncogenesis. We examined protein PTMs in the blood samples from patients with kidney cancer. Conformational changes in proteins after modification were analyzed. The proteins were analyzed using ultra-high resolution HPLC-MS/MS and structural analysis was performed with the AMBER and GROMACS software packages. Fifteen proteins containing PTMs were identified in blood samples from patients with kidney cancer. For proteins with PDB structures, a comparative analysis of the structural changes accompanying the modifications was performed. Results revealed that PTMs are localized in stable and compact space protein globule motifs that are exposed to a solvent. The phenomenon of modification is accompanied, as a rule, by an increase in the area available for the solvent of the modified amino acid residue and its active environment.